At a glance
Type: Growth hormone secretagogue peptide (GHRP-class)
Category: Growth hormone secretagogue research
Alternate names: IPA, GHRP-6 related pentapeptide, NNC 26-0161
Historical context
Developed by Novo Nordisk in the 1990s as a selective secretagogue candidate. Research supply demand reflects secretagogue model literature rather than clinical applications.
Active research areas
Pituitary somatotroph assays
Selective GH release comparisons
Combination studies with GHRH analogs
Receptor binding characterization
Material availability
VaultLabs catalog SKUs: cjc-1295-ipamorelin-5mg — view product pages for current AED pricing and lot documentation.
COA verification available per batch when published to the documentation portal.
Combination research context
Literature often references Ipamorelin alongside CJC-1295 in secretagogue model systems. VaultLabs supplies a combined blend SKU — verify component documentation on COA.
All VaultLabs materials are supplied strictly for in vitro laboratory and research use. Not for human consumption, medical use, or personal application.